These observations emphasize the potential importance of LDL-C and non-HDL-C in pointing to patients at increased risk for Lp(a)-mediated disease, as well as preventative strategies to mitigate the risk conferred by elevated Lp(a) levels (e.g., LDL-C or non-HDL-C lowering) especially for patients with diabetes. Here, LPA is linked to diabetes mellitus.